Global 5'Nucleotidase Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 119 pages | ID: G125C7A499AEN
GlobalInfoResearch

Abstracts

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5'-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5'nucleotides.

Scope of the Report:

Colorectal Cancer, Fallopian Tube Cancer, Gastric Cancer, Metastatic Colorectal Cancer, Others are dominant players in the global 5 Nucleotidase market.

The global 5'Nucleotidase market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of 5'Nucleotidase.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the 5'Nucleotidase market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the 5'Nucleotidase market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Bristol-Myers Squibb
• Corvus Pharmaceuticals
• Innate Pharma
• MedImmune
• Surface Oncology
• Vitae Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Single Dose
• Combination Therapy

Market Segment by Applications, can be divided into

• Hospitals
• Ambulatory Surgical Centers
• Others

Contents

1 5'NUCLEOTIDASE MARKET OVERVIEW

1.1 Product Overview and Scope of 5'Nucleotidase
1.2 Classification of 5'Nucleotidase by Types
  1.2.1 Global 5'Nucleotidase Revenue Comparison by Types (2017-2023)
  1.2.2 Global 5'Nucleotidase Revenue Market Share by Types in 2017
  1.2.3 Single Dose
  1.2.4 Combination Therapy
1.3 Global 5'Nucleotidase Market by Application
  1.3.1 Global 5'Nucleotidase Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Others
1.4 Global 5'Nucleotidase Market by Regions
  1.4.1 Global 5'Nucleotidase Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) 5'Nucleotidase Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) 5'Nucleotidase Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 5'Nucleotidase Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) 5'Nucleotidase Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) 5'Nucleotidase Status and Prospect (2013-2023)
1.5 Global Market Size of 5'Nucleotidase (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bristol-Myers Squibb
  2.1.1 Business Overview
  2.1.2 5'Nucleotidase Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bristol-Myers Squibb 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.2 Corvus Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 5'Nucleotidase Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Corvus Pharmaceuticals 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.3 Innate Pharma
  2.3.1 Business Overview
  2.3.2 5'Nucleotidase Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Innate Pharma 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.4 MedImmune
  2.4.1 Business Overview
  2.4.2 5'Nucleotidase Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 MedImmune 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.5 Surface Oncology
  2.5.1 Business Overview
  2.5.2 5'Nucleotidase Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Surface Oncology 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
2.6 Vitae Pharmaceuticals
  2.6.1 Business Overview
  2.6.2 5'Nucleotidase Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Vitae Pharmaceuticals 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL 5'NUCLEOTIDASE MARKET COMPETITION, BY PLAYERS

3.1 Global 5'Nucleotidase Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 5'Nucleotidase Players Market Share
  3.2.2 Top 10 5'Nucleotidase Players Market Share
3.3 Market Competition Trend

4 GLOBAL 5'NUCLEOTIDASE MARKET SIZE BY REGIONS

4.1 Global 5'Nucleotidase Revenue and Market Share by Regions
4.2 North America 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.3 Europe 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.5 South America 5'Nucleotidase Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa 5'Nucleotidase Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA 5'NUCLEOTIDASE REVENUE BY COUNTRIES

5.1 North America 5'Nucleotidase Revenue by Countries (2013-2018)
5.2 USA 5'Nucleotidase Revenue and Growth Rate (2013-2018)
5.3 Canada 5'Nucleotidase Revenue and Growth Rate (2013-2018)
5.4 Mexico 5'Nucleotidase Revenue and Growth Rate (2013-2018)

6 EUROPE 5'NUCLEOTIDASE REVENUE BY COUNTRIES

6.1 Europe 5'Nucleotidase Revenue by Countries (2013-2018)
6.2 Germany 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.3 UK 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.4 France 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.5 Russia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
6.6 Italy 5'Nucleotidase Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC 5'NUCLEOTIDASE REVENUE BY COUNTRIES

7.1 Asia-Pacific 5'Nucleotidase Revenue by Countries (2013-2018)
7.2 China 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.3 Japan 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.4 Korea 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.5 India 5'Nucleotidase Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia 5'Nucleotidase Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA 5'NUCLEOTIDASE REVENUE BY COUNTRIES

8.1 South America 5'Nucleotidase Revenue by Countries (2013-2018)
8.2 Brazil 5'Nucleotidase Revenue and Growth Rate (2013-2018)
8.3 Argentina 5'Nucleotidase Revenue and Growth Rate (2013-2018)
8.4 Colombia 5'Nucleotidase Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE 5'NUCLEOTIDASE BY COUNTRIES

9.1 Middle East and Africa 5'Nucleotidase Revenue by Countries (2013-2018)
9.2 Saudi Arabia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.3 UAE 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.4 Egypt 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.5 Nigeria 5'Nucleotidase Revenue and Growth Rate (2013-2018)
9.6 South Africa 5'Nucleotidase Revenue and Growth Rate (2013-2018)

10 GLOBAL 5'NUCLEOTIDASE MARKET SEGMENT BY TYPE

10.1 Global 5'Nucleotidase Revenue and Market Share by Type (2013-2018)
10.2 Global 5'Nucleotidase Market Forecast by Type (2018-2023)
10.3 Single Dose Revenue Growth Rate (2013-2023)
10.4 Combination Therapy Revenue Growth Rate (2013-2023)

11 GLOBAL 5'NUCLEOTIDASE MARKET SEGMENT BY APPLICATION

11.1 Global 5'Nucleotidase Revenue Market Share by Application (2013-2018)
11.2 5'Nucleotidase Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)

12 GLOBAL 5'NUCLEOTIDASE MARKET SIZE FORECAST (2018-2023)

12.1 Global 5'Nucleotidase Market Size Forecast (2018-2023)
12.2 Global 5'Nucleotidase Market Forecast by Regions (2018-2023)
12.3 North America 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.4 Europe 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.6 South America 5'Nucleotidase Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa 5'Nucleotidase Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure 5'Nucleotidase Picture
Table Product Specifications of 5'Nucleotidase
Table Global 5'Nucleotidase and Revenue (Million USD) Market Split by Product Type
Figure Global 5'Nucleotidase Revenue Market Share by Types in 2017
Figure Single Dose Picture
Figure Combination Therapy Picture
Table Global 5'Nucleotidase Revenue (Million USD) by Application (2013-2023)
Figure 5'Nucleotidase Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Market 5'Nucleotidase Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America 5'Nucleotidase Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe 5'Nucleotidase Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific 5'Nucleotidase Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America 5'Nucleotidase Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa 5'Nucleotidase Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global 5'Nucleotidase Revenue (Million USD) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb 5'Nucleotidase Type and Applications
Table Bristol-Myers Squibb 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
Table Corvus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Corvus Pharmaceuticals 5'Nucleotidase Type and Applications
Table Corvus Pharmaceuticals 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
Table Innate Pharma Basic Information, Manufacturing Base and Competitors
Table Innate Pharma 5'Nucleotidase Type and Applications
Table Innate Pharma 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
Table MedImmune Basic Information, Manufacturing Base and Competitors
Table MedImmune 5'Nucleotidase Type and Applications
Table MedImmune 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
Table Surface Oncology Basic Information, Manufacturing Base and Competitors
Table Surface Oncology 5'Nucleotidase Type and Applications
Table Surface Oncology 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
Table Vitae Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Vitae Pharmaceuticals 5'Nucleotidase Type and Applications
Table Vitae Pharmaceuticals 5'Nucleotidase Revenue, Gross Margin and Market Share (2016-2017)
Table Global 5'Nucleotidase Revenue (Million USD) by Players (2013-2018)
Table Global 5'Nucleotidase Revenue Share by Players (2013-2018)
Figure Global 5'Nucleotidase Revenue Share by Players in 2016
Figure Global 5'Nucleotidase Revenue Share by Players in 2017
Figure Global Top 5 Players 5'Nucleotidase Revenue Market Share in 2017
Figure Global Top 10 Players 5'Nucleotidase Revenue Market Share in 2017
Figure Global 5'Nucleotidase Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global 5'Nucleotidase Revenue (Million USD) by Regions (2013-2018)
Table Global 5'Nucleotidase Revenue Market Share by Regions (2013-2018)
Figure Global 5'Nucleotidase Revenue Market Share by Regions (2013-2018)
Figure Global 5'Nucleotidase Revenue Market Share by Regions in 2017
Figure North America 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Europe 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure South America 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Table North America 5'Nucleotidase Revenue by Countries (2013-2018)
Table North America 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure North America 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure North America 5'Nucleotidase Revenue Market Share by Countries in 2017
Figure USA 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Canada 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Mexico 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Table Europe 5'Nucleotidase Revenue (Million USD) by Countries (2013-2018)
Figure Europe 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure Europe 5'Nucleotidase Revenue Market Share by Countries in 2017
Figure Germany 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure UK 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure France 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Russia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Italy 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Table Asia-Pacific 5'Nucleotidase Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific 5'Nucleotidase Revenue Market Share by Countries in 2017
Figure China 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Japan 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Korea 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure India 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Southeast Asia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Table South America 5'Nucleotidase Revenue by Countries (2013-2018)
Table South America 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure South America 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure South America 5'Nucleotidase Revenue Market Share by Countries in 2017
Figure Brazil 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Argentina 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Colombia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Table Middle East and Africa 5'Nucleotidase Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa 5'Nucleotidase Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa 5'Nucleotidase Revenue Market Share by Countries in 2017
Figure Saudi Arabia 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure UAE 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Egypt 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure Nigeria 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Figure South Africa 5'Nucleotidase Revenue and Growth Rate (2013-2018)
Table Global 5'Nucleotidase Revenue (Million USD) by Type (2013-2018)
Table Global 5'Nucleotidase Revenue Share by Type (2013-2018)
Figure Global 5'Nucleotidase Revenue Share by Type (2013-2018)
Figure Global 5'Nucleotidase Revenue Share by Type in 2017
Table Global 5'Nucleotidase Revenue Forecast by Type (2018-2023)
Figure Global 5'Nucleotidase Market Share Forecast by Type (2018-2023)
Figure Global Single Dose Revenue Growth Rate (2013-2018)
Figure Global Combination Therapy Revenue Growth Rate (2013-2018)
Table Global 5'Nucleotidase Revenue by Application (2013-2018)
Table Global 5'Nucleotidase Revenue Share by Application (2013-2018)
Figure Global 5'Nucleotidase Revenue Share by Application (2013-2018)
Figure Global 5'Nucleotidase Revenue Share by Application in 2017
Table Global 5'Nucleotidase Revenue Forecast by Application (2018-2023)
Figure Global 5'Nucleotidase Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global 5'Nucleotidase Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global 5'Nucleotidase Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global 5'Nucleotidase Revenue Market Share Forecast by Regions (2018-2023)
Figure North America 5'Nucleotidase Revenue Market Forecast (2018-2023)
Figure Europe 5'Nucleotidase Revenue Market Forecast (2018-2023)
Figure Asia-Pacific 5'Nucleotidase Revenue Market Forecast (2018-2023)
Figure South America 5'Nucleotidase Revenue Market Forecast (2018-2023)
Figure Middle East and Africa 5'Nucleotidase Revenue Market Forecast (2018-2023)